ABSTRACT
The incidence of dengue virus disease has increased globally across the past half-century, with highest number of cases ever reported in 2019. We analyzed climatological, epidemiological, and phylogenomic data to investigate drivers of two decades of dengue in Cambodia, an understudied endemic setting. Using epidemiological models fit to a 19-year dataset, we first demonstrate that climate-driven transmission alone is insufficient to explain three epidemics across the time series. We then use wavelet decomposition to highlight enhanced annual and multiannual synchronicity in dengue cycles between provinces in epidemic years, suggesting a role for climate in homogenizing dynamics across space and time. Assuming reported cases correspond to symptomatic secondary infections, we next use an age-structured catalytic model to estimate a declining force of infection for dengue through time, which elevates the mean age of reported cases in Cambodia. Reported cases in >70 year-old individuals in the most recent 2019 epidemic are best explained when also allowing for waning multitypic immunity and repeat symptomatic infections in older patients. We support this work with phylogenetic analysis of 192 dengue virus (DENV) genomes that we sequenced between 2019-2022, which document emergence of DENV-2 Cosmopolitan Genotype-II into Cambodia. This lineage demonstrates phylogenetic homogeneity across wide geographic areas, consistent with invasion behavior and in contrast to high phylogenetic diversity exhibited by endemic DENV-1. Finally, we simulate an age-structured, mechanistic model of dengue dynamics to demonstrate how expansion of an antigenically distinct lineage that evades preexisting multitypic immunity effectively reproduces the older-age infections witnessed in our data.
CLINICAL TRIAL NUMBERS NCT04034264 and NCT03534245.
SIGNIFICANCE STATEMENT The year 2019 witnessed the highest number of dengue cases ever reported, including in Cambodia, a Southeast Asian country with endemic transmission. We analyzed 19 years of national dengue surveillance data for Cambodia to demonstrate how increasing temperature and precipitation enhance similarity in dengue incidence across space and time, particularly in epidemic years. We document how two decades of demographic transition has depressed the rate at which dengue infections are acquired, thus increasing the age of reported infection. In 2019, expansion of a genetically distinct DENV-2 lineage into Cambodia likely underpinned repeated symptomatic infections in older-age individuals to drive high caseloads. As climates warm, we anticipate more synchronized dynamics globally and a shifting burden of symptomatic disease into older cohorts.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by the Division of Intramural Research at the National Institute of Allergy and Infectious Diseases at the National Institutes of Health and the Bill and Melinda Gates Foundation.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The National Ethics Committee for Human Research of the Cambodian Ministry of Health gave ethical approval for this work. The Institutional Review Board of the US National Institutes of Health gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Author Contributions: CEB and JEM conceived the study. JEM, JAB, HR, RL, and SC conducted the febrile surveillance study and collected samples for mNGS in 2019-2022. VA, CMT, JLD, JAB, SC, SL, CY, OM, SM, and JEM carried out RT-qPCR to identify dengue-positive samples, as well as library preparation and mNGS. Other ancillary demographic data collection and analyses were performed by RL, KS, CY, FO, and ARP. DP, CL, and JEM set up geospatial system for patients. CEB and JAB generated consensus dengue genomes for upload to NCBI. CEB carried out all TSIR, FOI, phylogenetic, and simulation analysis, with help from KY, YL, GN, CR, and MB. CR and CEB extended the catalytic model to include waning multitypic immunity. CEB and JEM wrote the first draft of the manuscript. All authors approved and contributed to subsequent drafts of the manuscript and agree with the results presented.
Competing Interest Statement: No competing interests.
We have changed all place names associated with dengue genotypes to numerical names, in keeping with more recent standards in the field. We have also edited some syntax that was confusing and reran our figure 5 simulations using just the age structure estimated from the first half of the time series to enhance clarity.
Data Availability
All genome sequence data from this study have been submitted to the NCBI Sequence Read Archive under Bioproject ID PRJNA681566. Consensus DENV sequences are also available in GenBank, under the following accession numbers: DENV-1: OK159935-OK159976, OL411495-OL411499, and OL412140, OL412678, and OL412703; DENV-2: OL414717-OL414765, OL412740, OL420733 and OL435143; DENV-4: MZ976858-MZ976860).
https://github.com/chanzuckerberg/idseq-workflows
https://artic.readthedocs.io/en/latest/
https://docs.google.com/document/d/1RtNQc1D4or_ys7OxCCBjh4SDIdy7JaI4IE7if8EkHgE/edit
